FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA supplemental approval for a diclofenac sodium product manufactured by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Dysmenorrhea
• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• DICLOFENAC SODIUM (DICLOFENAC SODIUM)

Snippet

SUPPL AP for DICLOFENAC SODIUM (DICLOFENAC SODIUM)